Today, HALO Research, UK, has been set up to take advantage of the unique regulatory environment that exists in the UK post-Brexit.

The Company is focused on providing regulatory services, access to biological samples for pre-market testing and go-to-market planning in the diagnostic and medical device space.

The company is also able to provide Authorised Representatives for non-EU based companies.

Alan Boyce who leads the UK office said: “Many companies are finding it a challenge to decide what clinical and regulatory work is necessary to ensure the optimal access to both the UK and EU markets. We at HALO Research are able to help companies manage the transition and ensure that their plans to market are optimised”.